ower respiratory tract Microbiome in patients with Lung cancer (LML)
Not Applicable
Recruiting
- Conditions
- J44.9Malignant neoplasm of bronchus and lungChronic obstructive pulmonary disease, unspecifiedC34
- Registration Number
- DRKS00025048
- Lead Sponsor
- niversitätsklinikum FreiburgKlinik für Thoraxchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
1. Patients with a) suspected or proven lung cancer (study group) or b) COPD (control
group)
2. scheduled for bronchoscopy and/or surgical resection at the Medical Center Freiburg
3. Male and female patients, = 18 years of age
Exclusion Criteria
1. Patients with history of systemic corticosteroids and/or immunosuppressive therapy in the last 12 months before enrolment
2. Patients with history of systemic antibiotics for any reason in the last 4 weeks before enrolment
3. Patients with history of chemotherapy and/or radiation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Composition of lower respiratory tract microbiota in patients with different histological types and stages of lung cancer
- Secondary Outcome Measures
Name Time Method • Development of post-operative pneumonia after lung resection for lung cancer<br>• Tumour recurrence und survival